Bluebook
Pharma Services: Drug Development BlueBook February 2025
2025 - February: Report on M&A and financing activity in the pharma services drug development industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Sigma Healthcare was acquired by CW Group
- Amphenol announced its acquisition of LifeSync
- Neurocare closed a $20MM Series A Financing, led by TVM Capital Healthcare Partners and Impact Expansion Management